Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Dymista vs Flixonase in Nasal Tissue
NCT02883439Phase 1Withdrawn
- Sponsor
- Ghent University Hospital
- Start
- Aug 2016
- Primary completion
- Mar 2020
- Countries
- 1
01
Overview
Phase 1, open-label trial of fluticasone propionate nasal spray in allergic rhinitis (AR), non-allergic rhinitis (NAR), sinusitis and 1 more, sponsored by Ghent University Hospital. Primary endpoint: Bioavailability of MP29-02 in human nasal mucosa compared to commercially available fluticasone propionate at 1 hour. Planned start Aug 2016; status: withdrawn.
02
Drugs
fluticasone propionate nasal spray
03
Conditions
allergic rhinitis (AR)non-allergic rhinitis (NAR)sinusitisnasal polyposis
Beyond the preview
Go deeper on NCT02883439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02883439.